Suppr超能文献

巴西的疟疾:概述。

Malaria in Brazil: an overview.

机构信息

Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fiocruz, Pavilhão Leônidas Deane-5 degrees andar, Av. Brasil 4365, Manguinhos, Rio de Janeiro, RJ-CEP 21.045-900, RJ-Brazil.

出版信息

Malar J. 2010 Apr 30;9:115. doi: 10.1186/1475-2875-9-115.

Abstract

Malaria is still a major public health problem in Brazil, with approximately 306,000 registered cases in 2009, but it is estimated that in the early 1940s, around six million cases of malaria occurred each year. As a result of the fight against the disease, the number of malaria cases decreased over the years and the smallest numbers of cases to-date were recorded in the 1960s. From the mid-1960s onwards, Brazil underwent a rapid and disorganized settlement process in the Amazon and this migratory movement led to a progressive increase in the number of reported cases. Although the main mosquito vector (Anopheles darlingi) is present in about 80% of the country, currently the incidence of malaria in Brazil is almost exclusively (99,8% of the cases) restricted to the region of the Amazon Basin, where a number of combined factors favors disease transmission and impair the use of standard control procedures. Plasmodium vivax accounts for 83,7% of registered cases, while Plasmodium falciparum is responsible for 16,3% and Plasmodium malariae is seldom observed. Although vivax malaria is thought to cause little mortality, compared to falciparum malaria, it accounts for much of the morbidity and for huge burdens on the prosperity of endemic communities. However, in the last few years a pattern of unusual clinical complications with fatal cases associated with P. vivax have been reported in Brazil and this is a matter of concern for Brazilian malariologists. In addition, the emergence of P. vivax strains resistant to chloroquine in some reports needs to be further investigated. In contrast, asymptomatic infection by P. falciparum and P. vivax has been detected in epidemiological studies in the states of Rondonia and Amazonas, indicating probably a pattern of clinical immunity in both autochthonous and migrant populations. Seropidemiological studies investigating the type of immune responses elicited in naturally-exposed populations to several malaria vaccine candidates in Brazilian populations have also been providing important information on whether immune responses specific to these antigens are generated in natural infections and their immunogenic potential as vaccine candidates. The present difficulties in reducing economic and social risk factors that determine the incidence of malaria in the Amazon Region render impracticable its elimination in the region. As a result, a malaria-integrated control effort--as a joint action on the part of the government and the population--directed towards the elimination or reduction of the risks of death or illness, is the direction adopted by the Brazilian government in the fight against the disease.

摘要

疟疾仍然是巴西的一个主要公共卫生问题,2009 年登记的病例约为 306000 例,但据估计,在 20 世纪 40 年代初,每年大约有 600 万例疟疾病例。由于与疾病作斗争,疟疾病例数量逐年减少,到目前为止,记录到的病例数量是 20 世纪 60 年代最少的。自 20 世纪 60 年代中期以来,巴西的亚马逊地区经历了快速和无组织的定居进程,这种移民运动导致报告病例数逐渐增加。尽管主要的疟蚊(按蚊 darlingi)存在于该国约 80%的地区,但目前巴西疟疾的发病率几乎完全(99.8%的病例)仅限于亚马逊流域地区,那里有许多综合因素有利于疾病传播,并损害了标准控制程序的使用。间日疟原虫占登记病例的 83.7%,而恶性疟原虫占 16.3%,间日疟原虫很少见。虽然间日疟原虫被认为死亡率低于恶性疟原虫,但它导致了大部分发病率,并给流行地区的繁荣带来了巨大负担。然而,在过去几年中,巴西报告了一些不寻常的临床并发症病例,包括与间日疟原虫有关的死亡病例,这引起了巴西疟疾学家的关注。此外,一些报告显示,间日疟原虫株对氯喹产生了耐药性,这需要进一步调查。相比之下,在朗多尼亚州和亚马逊州的流行病学研究中,已经检测到恶性疟原虫和间日疟原虫无症状感染,这表明在当地人和移民群体中可能存在临床免疫模式。针对巴西人群中几种疟疾候选疫苗的自然暴露人群中引发的免疫反应类型的血清流行病学研究,也为这些抗原产生的特异性免疫反应是否在自然感染中产生及其作为疫苗候选物的免疫原性提供了重要信息。目前,在亚马逊地区减少决定疟疾发病率的经济和社会风险因素方面存在困难,这使得该地区消除疟疾变得不切实际。因此,巴西政府采取了一种综合疟疾控制措施——作为政府和民众的联合行动——旨在消除或减少死亡或患病的风险,这是巴西政府在抗击疟疾方面采取的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ab/2891813/edfa0670aa22/1475-2875-9-115-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验